Transferrin and hemoglobin iron-binding sites

Transferrin and hemoglobin iron-binding sites are the specific molecular regions within these two distinct metalloproteins that coordinate iron ions to facilitate essential physiological processes. Transferrin is a serum glycoprotein responsible for the safe transport of ferric iron (Fe3+) through the circulatory system, utilizing two high-affinity binding sites to prevent iron-mediated oxidative damage [1]. Hemoglobin, the primary component of red blood cells, contains four heme groups where ferrous iron (Fe2+) reversibly binds oxygen for delivery to tissues [2]. These sites are of significant therapeutic interest in conditions of iron dysregulation; for example, iron chelators such as deferoxamine and deferasirox are used to treat systemic iron overload by sequestering iron from these proteins or the labile iron pool [3]. Additionally, the saturation and integrity of these sites are critical for maintaining systemic iron homeostasis and preventing cellular toxicity [5]. Because this entry combines two structurally and functionally distinct proteins into a single category based on a shared chemical characteristic, it is not classified as a single canonical therapeutic target in standard pharmacology [5]. The coordination chemistry at these sites is highly specific, involving residues like aspartate and histidine in transferrin, and the porphyrin ring in hemoglobin [1, 2]. Monitoring these sites via clinical assays is a key diagnostic tool for assessing iron status in patients with anemia or chronic disease [5].

Other names

Iron-binding pocketsHeme iron siteTransferrin iron-binding domainFerric ion binding sites

Iron chelation involving the competitive sequestration of iron ions from protein binding sites or the labile iron pool.